Moveltipril

CAS No. 85856-54-8

Moveltipril( —— )

Catalog No. M34107 CAS No. 85856-54-8

Moveltipril (Moveltipril calcium) is a potent angiotensin-converting enzyme (ACE) inhibitor.Moveltipril is converted to captopril in the body for action.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
2MG 112 Get Quote
5MG 170 Get Quote
10MG 282 Get Quote
25MG 517 Get Quote
50MG 822 Get Quote
100MG 1305 Get Quote
200MG 1755 Get Quote
500MG Get Quote Get Quote
1G Get Quote Get Quote

Biological Information

  • Product Name
    Moveltipril
  • Note
    Research use only, not for human use.
  • Brief Description
    Moveltipril (Moveltipril calcium) is a potent angiotensin-converting enzyme (ACE) inhibitor.Moveltipril is converted to captopril in the body for action.
  • Description
    Moveltipril (Moveltipril calcium; MC-838) is a potent angiotensin converting enzyme (ACE) inhibitor.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    ——
  • Pathway
    Endocrinology/Hormones
  • Target
    RAAS
  • Recptor
    RAAS
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    85856-54-8
  • Formula Weight
    398.52
  • Molecular Formula
    C19H30N2O5S
  • Purity
    >98% (HPLC)
  • Solubility
    In Vitro:?DMSO : 100 mg/mL (250.93 mM; Ultrasonic )
  • SMILES
    C[C@H](CSC(=O)[C@@H](C)NC(=O)C1CCCCC1)C(=O)N1CCC[C@H]1C(O)=O
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1. A Salvetti, et al. Newer ACE inhibitors. A look at the future. ?
molnova catalog
related products
  • Zabicipril

    Zabicipril is a novel orally available angiotensin-converting enzyme inhibitor, a prodrug with antihypertensive activity following in vivo de-esterification.

  • Angiotensin III, hum...

    Angiotensin III, human, mouse is a heptapeptide, acts as an endogenous angiotensin type 2 receptor (AT2R) agonist, with IC50s of 0.648 nM and 21.1 nM for AT2R and AT1R, respectively.

  • Plantainoside D

    Plantainoside D shows potent antioxidative effects as those of ascorbic acid it shows angiotensin-converting enzyme (ACE) inhibitory inhibitory activity in vitro with the IC(50) value of 2.17 mM it also shows inhibitory activity against PKCalpha with the IC50 value14.8microM.?